Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Hank case study – Nu.Q® Vet Cancer Test

Monday, January 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article features Dr. Sue Ettinger discussing Hank's experience with the Nu.Q® Vet Cancer Test. It highlights the potential publication of a study in a peer-reviewed journal, which may unlock a $5 million milestone payment. Additionally, it mentions the first automated version of the test developed in collaboration with Fujifilm Vet Systems.
Price reaction · baseline $20 (2024-01-22T14:46:00.000Z) · hit during market hours · 13 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Hank's story highlights the effectiveness of the Nu.Q® Vet Cancer Test.
  • The upcoming publication in a peer-reviewed journal could lead to significant funding.
  • The partnership with Fujifilm Vet Systems marks a milestone in automated cancer testing.

Full Press Release Details

Watch our short video, featuring Dr. Sue Ettinger, aka Dr. Sue Cancer Vet, as she describes Hank’s story with the Nu.Q ® Vet Cancer Test.

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool designed to detect cancer in pets.

Who is Dr. Sue Ettinger?

Dr. Sue Ettinger, known as Dr. Sue Cancer Vet, is a veterinarian specializing in oncology.

What milestone is associated with the Nu.Q® Vet Cancer Test?

The publication of a study in a peer-reviewed journal may unlock a $5 million milestone payment.

What partnership is mentioned in the article?

The article mentions a partnership with Fujifilm Vet Systems for an automated version of the test.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare cancer test veterinary oncology Fujifilm Vet Systems Hank case study
Last updated: Jan 22, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk